Specialty drug costs have risen to a predominant part of benefit spend. In addition, it lies within a complex structure, and ever-changing landscape. However, it is still a largely unmanaged and cryptic aspect within an organization’s benefit portfolio, allowing costs to continue to rise.
This “master class” will discuss specialty drugs, the current problems with its management and solutions you can implement in your organization. Together we will crack the code to real solutions in your specialty drug management.
Key Takeaways:
The move toward high-performance and high-value healthcare
In-depth analysis of the latest trends and solutions that improve heath outcomes, strengthen accountability, and cut costs
Actionable insights on how to drive better health outcomes at a far lower cost for your organization.
Profiles in innovative solutions and organizations that are “walking the walk” when it comes to delivering better savings, outcomes, and more
The move toward high-performance and high-value healthcare
In-depth analysis of the latest trends and solutions that improve heath outcomes, strengthen accountability, and cut costs
Actionable insights on how to drive better health outcomes at a far lower cost for your organization.
Profiles in innovative solutions and organizations that are “walking the walk” when it comes to delivering better savings, outcomes, and more
